Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Evogene Ltd.
  6. News
  7. Summary
    EVGN   IL0011050551

EVOGENE LTD.

(EVGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Evogene's Biomica Gets Israeli Nod To Move Ahead With Cancer Trial

01/11/2022 | 07:25am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BRISTOL-MYERS SQUIBB COMPANY 0.01% 76.8 Delayed Quote.23.02%
EVOGENE LTD. -0.10% 3.08 End-of-day quote.-42.70%
All news about EVOGENE LTD.
05:13aBiomica to Present at the ASCO 2022 Annual Meeting - Evogene
AQ
05/23EVOGENE : Biomica to Present at the ASCO 2022 Annual Meeting
PU
05/17Biomica to Present at the 2022 Digestive Disease Week (DDW) Conference - Evogene
AQ
05/12Lavie Bio Announces Successful Product Launch of its Bio-Inoculant result(TM) for the 2..
AQ
05/11EVOGENE : Lavie Bio Announces Successful Product Launch of its Bio-Inoculant result™..
PU
05/10Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2..
AQ
04/26EVOGENE : AgPlenus Investor Presentation - Form 6-K
PU
04/26EVOGENE : AgPlenus Investor Presentation
PU
04/14Biomica Announces Agreement with Sheba Medical Center for Joint Microbiome Clinical Res..
AQ
04/13Evogene Subsidiary Biomica Signs Microbiome Clinical Research Deal With Sheba Medical C..
MT
More news
Analyst Recommendations on EVOGENE LTD.
More recommendations
Financials (USD)
Sales 2022 2,52 M - -
Net income 2022 -30,2 M - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 38,0 M 38,0 M -
Capi. / Sales 2022 15,1x
Capi. / Sales 2023 2,12x
Nbr of Employees 137
Free-Float 93,9%
Chart EVOGENE LTD.
Duration : Period :
Evogene Ltd. Technical Analysis Chart | EVGN | IL0011050551 | MarketScreener
Technical analysis trends EVOGENE LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Ofer Haviv Chief Financial & Operational Officer
Yaron Eldad Chief Financial Officer
Sarit Firon Chairman
Mark Kapel Chief Technology Officer
Eyal Emmanuel Vice President-Corporate Strategy
Sector and Competitors
1st jan.Capi. (M$)
EVOGENE LTD.-42.70%38
MODERNA, INC.-45.81%54 740
LONZA GROUP AG-27.15%42 618
IQVIA HOLDINGS INC.-27.91%38 497
SEAGEN INC.-9.87%25 649
ICON PUBLIC LIMITED COMPANY-29.74%17 688